Some alcohol, but not more than 1 drink per day, was linked to a 55% lower risk of type 2 diabetes in women with a history of gestational diabetes.
For women with a history of gestational diabetes, habitual light alcohol consumption is associated with a lower risk of type 2 diabetes (T2D), a study published in JAMA Network Open found.
In the study, habitual alcohol intake was defined as 5.0 to 14.9 grams per day (g/d) or approximately 0.5-1 alcoholic drink per day. Researchers found that habitual alcohol consumption was associated with a 55% lower risk for T2D (HR, 0.45; 95% CI, 0.33-0.61) compared with no alcohol consumption, independent of demographic and other major dietary and lifestyle factors.
Since women with gestational diabetes—diabetes during pregnancy—are at a higher risk for T2D, identifying dietary and lifestyle factors that can be modified can help delay or prevent progression to T2D.
The prospective cohort study focused on 4740 women with a history of gestational diabetes with a mean (SD) age at baseline of 38.2 (5.0) years. Researchers followed up for up to 27 years between 1991 and 2017 with a median follow-up time of 24 years (interquartile range, 18-28 years).
When adjusted for BMI, habitual consumption was associated with a 41% lower risk for T2D (HR, 0.59; 95% CI, 0.42-0.81). The study found no association of alcohol consumption between 0.1 and 4.9 g/d or 15.0 g/d or more (maximum, 74.2 g/d) with T2D risk.
“These findings should be interpreted in the context of other known risks and benefits of alcohol consumption when considering clinical recommendations for individual women with a history of gestational diabetes,” the authors noted.
Model covariates included:
The researchers also conducted analyses by type of alcohol, including liquor, wine, and beer.
In fully adjusted models, liquor consumption was not associated with risk of T2D compared with no liquor consumption.
In multivariable analyses, beer consumption of 1.2 to 2 servings per week and 3.3 to 6 servings per week was associated with a 51% and 45% decreased risk of T2D compared with no beer consumption, respectively. When adjusted for BMI, 1.2 to 2 servings per week was linked to a 45% decreased risk and 3.3 to 6 servings per week was linked to a 40% decreased risk.
In the age-adjusted and multivariable analyses, wine consumption of 3.5 to 6 servings per week was associated with a 54% and 46% decreased risk of T2D, respectively, compared with no wine consumption. However, when adjusted for BMI, there was only a 27% decreased risk.
“Although our findings suggest that alcohol consumption of 5.0 to 14.9 g/d compared with no consumption is associated with a 41% lower risk for type 2 diabetes among women with a history of gestational diabetes, they should not be interpreted in isolation from other health outcomes” the authors emphasized. “Among those who consume alcohol, consumption of 0.1 to 14.9 g/d has been associated with improved cardiovascular outcomes and lower all-cause mortality, although consumption levels as low as 5 to 9 g/d have been associated with a modest increase in the risk for breast cancer.”
Reference:
Hinkle SN, Bao W, Wu J, et al. Association of habitual alcohol consumption with long-term risk of type 2 diabetes among women with a history of gestational diabetes. JAMA Netw Open. Published online September 9, 2021. doi:10.1001/jamanetworkopen.2021.24669
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
Team-Based CINEMA Program Targets SDOH and Precision Care in Diabetes
December 20th 2024Ian Neeland, MD, discusses the CINEMA program's impact on addressing social determinants of health (SDOH) in Ohio and the importance of precision risk tests to reduce cardiovascular metabolic disease risk.
Read More